New GMP iPSC Lines and Improved Differentiation Workflows for Cell Therapy
Date: December 4, 2023
Time: 9:00 AM
Catalent’s iPSC experts discuss their GMP induced pluripotent stem cell (iPSC) platform featuring upcoming new cell lines and a simple high-efficiency gene editing workflow, as well as novel differentiation protocols.
Methods for the generation of iPSCs, as well as for their conversion into defined cell types, have substantially evolved over the last years. For these to be applied in cell therapy, the underlying procedures must be as simple as possible, display a high degree of robustness, be cost-effective, scalable and overall GMP-compatible. In this webinar, Catalent’s iPSC experts will discuss their GMP iPSC platform featuring upcoming new cell lines and a simple high-efficiency gene editing workflow.
Also, our speakers will highlight the evolution of novel differentiation protocols for key medical cell types – RPE cells, MSCs, cardiomyocytes, and immune cells (Mq, T, NK) – as developed from the start with a view on GMP manufacturing.
Key Learning Points:
- GMP-grade iPSC manufacturing and the importance of regulatory compliance
- iPSC-specific process development exemplified by an optimized gene editing workflow
- Specific challenges and solutions for generating medical cell types from iPSCs